Guardian Pharmacy Services, Inc. GRDN
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.31% | 13.54% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.31% | 13.54% | -- | -- | -- |
| Cost of Revenue | 7.57% | 11.92% | -- | -- | -- |
| Gross Profit | 21.54% | 20.13% | -- | -- | -- |
| SG&A Expenses | -28.14% | -30.05% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.71% | 2.18% | -- | -- | -- |
| Operating Income | 239.40% | 252.25% | -- | -- | -- |
| Income Before Tax | 250.35% | 236.29% | -- | -- | -- |
| Income Tax Expenses | 141.11% | 202.55% | -- | -- | -- |
| Earnings from Continuing Operations | 187.67% | 180.57% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 90.30% | 98.62% | -- | -- | -- |
| Net Income | 180.16% | 168.17% | -- | -- | -- |
| EBIT | 239.40% | 252.25% | -- | -- | -- |
| EBITDA | 369.51% | 398.05% | -- | -- | -- |
| EPS Basic | 160.73% | 151.30% | -- | -- | -- |
| Normalized Basic EPS | 224.97% | 208.34% | -- | -- | -- |
| EPS Diluted | 160.06% | 150.72% | -- | -- | -- |
| Normalized Diluted EPS | 222.86% | 206.74% | -- | -- | -- |
| Average Basic Shares Outstanding | 1.95% | 1.80% | -- | -- | -- |
| Average Diluted Shares Outstanding | 1.84% | 2.43% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |